JPRN-UMIN000017152已完成未知
Retrospective study of lyso-Gb3 plasma concentration in Fabry patients receiving ERT/Replagal - Retrospective study of lyso-Gb3 plasma concentration in Fabry patients receiving ERT/Replagal
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 100
研究概览
简要总结
Clin Exp Nephrol. doi: 10.1007/s10157-017-1525-3.(open access)
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •The following patients should not be enrolled to the study; Patients who are considered ineligible for the study by the investigator
研究者
相似试验
已完成
不适用
Validation study for lyso-Gb3 plasma concentration in healthy adult or child Japanese volunteersFabry diseaseJPRN-UMIN000016854Meiji Pharmaceutical University100
已完成
不适用
Evaluation of effectiveness of plasma lyso-Gb3 analogues as biomarker for diagnosing of Fabry diseaseFabry diseaseJPRN-UMIN000036465Department of Clinical Nephroscience, Niigata University Graduate School of Medical and Dental Sciences100
招募中
不适用
A study of usefulness of plasma lyso-GL-3 as a biomarker in patients with Fabry diseaseFabry diseaseJPRN-UMIN000037839Osaka University Graduate School of Medicine, Division of Health Science, Child Healthcare and Genetic Science Laboratory100
Unknown
不适用
Dosage of Plasma 1, 3-β-D-glucan for the Diagnosis of Candidemia.Infection, FungalNCT03674359Assistance Publique - Hôpitaux de Paris2,000
撤回
4 期
To Assess the Glycosphingolipid Clearance and Clinical Effects of Switching to Agalsidase Beta (Fabrazyme) Versus Continuing on Agalsidase Alfa (Replagal) in Male Patients With Classic Fabry DiseaseFabry DiseaseNCT04143958Sanofi